The report "Electrophysiology Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), and Region - Global Forecast to 2030", is estimated to grow from USD 8.51 billion in 2025 to USD 12.52 billion by 2030 at a CAGR of 8.0%. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions, are driving the growth of the electrophysiology market. This amalgamation of drivers has engendered substantial market growth. Continued technological advancements, heightened emphasis on non-invasive cancer interventions, and a supportive healthcare ecosystem are anticipated to sustain this upward trajectory.
Browse 186 market data Tables and 39 Figures spread through 238 Pages and in-depth TOC on "Electrophysiology Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/electrophysiology-market-200003281.html
The global lateral flow assay (LFA) market is propelled by several key factors such as the escalating prevalence of infectious diseases worldwide, growth in the aging population with rising chronic health needs, increased consumer adoption of user-friendly home-based testing kits, and the expanding deployment of point-of-care (POC) diagnostics in clinics, pharmacies, and remote health facilities. However, the market also faces significant constraints: although LFAs offer rapid, cost-effective solutions, their sensitivity and specificity often trail molecular and lab-based methods, resulting in occasional false positives or negatives that can undermine clinical confidence.
By technique, the sandwich assays segment is set to grow at the fastest rate in the lateral flow assay kits & reagents market across the forecast period
Based on technique, the lateral flow assay kits and reagents market is segmented into competitive, sandwich, and multiplex detection assays. Sandwich assays dominated the market, with a share in 2024. The large share of this segment can be attributed to the better assay sensitivity and specificity associated with sandwich assays and their extensive application in the measurement of critical analytes (such as cardiac and hepatitis markers).
By sample type, blood samples are estimated to account for the largest share in the lateral flow assays market during the forecast period.
Based on sample type, the lateral flow assays market is segmented into blood, urine, saliva, and other samples (nasal swabs, throat swabs, and vaginal fluid). Blood samples accounted for the largest market share in 2024. Technological advancements in testing methods have also improved accuracy and reduced turnaround times, making these tests more appealing for both healthcare providers and patients. The extensive use of blood samples in lateral flow tests and the easy detection of disease antibodies from blood samples are the key factors driving the growth of this market segment.
North America dominated the global lateral flow assays market in 2024.
The lateral flow assays market is segmented into six major segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. North America accounts for the largest market share in the lateral flow assays market in 2024. North America is the leading region in the lateral flow assays market due to its advanced healthcare infrastructure and significant investments in medical technology innovation. The presence of major medical device manufacturers and growing LFA evolution, leading in smartphone-enabled readers, AI-powered result interpretation, and multiplex testing formats.
Key Players
Prominent players in the lateral flow assays market include Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/